Stock data
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN) reported net income of -US$14.50M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$14.65M | -US$14.50M | — |
| 2024 | — | — | -US$19.13M | -US$18.62M | — |
| 2023 | — | — | -US$21.03M | -US$19.51M | — |
| 2022 | US$0.50M | — | -US$24.92M | -US$35.90M | — |
| 2021 | US$0.50M | — | -US$21.01M | -US$20.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.81M | — |
| 2026-03-31 | — | -US$4.25M | — |
| 2025-12-31 | — | -US$4.22M | — |
| 2025-09-30 | — | -US$3.43M | — |
| 2025-06-30 | — | -US$2.74M | — |
| 2025-03-31 | — | -US$4.10M | — |
| 2024-12-31 | — | -US$4.06M | — |
| 2024-09-30 | — | -US$4.85M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.